Cleave Biosciences Takes $42M Series A Round
Four venture firms provided the lion's share of the money, which will support development of oncology drugs that affect protein homeostasis pathways.
Four venture firms provided the lion's share of the money, which will support development of oncology drugs that affect protein homeostasis pathways.